LSM6
U6 snRNA-associated Sm-like protein LSm6
Also known as: LSM6_HUMAN, YDR378C
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P62312
- Gene
- LSM6
- Ensembl
- ENSG00000164167
- Chromosome
- 4
- Canonical length
- 80 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Actin filaments
OverviewNCBI Gene
Sm-like proteins were identified in a variety of organisms based on sequence homology with the Sm protein family (see SNRPD2; MIM 601061). Sm-like proteins contain the Sm sequence motif, which consists of 2 regions separated by a linker of variable length that folds as a loop. The Sm-like proteins are thought to form a stable heteromer present in tri-snRNP particles, which are important for pre-mRNA splicing.[supplied by OMIM, Apr 2004]
Canonical amino-acid sequenceUniProt
80 residues, UniProt reviewed canonical sequence.
>P62312|LSM6
1 MSLRKQTPSD FLKQIIGRPV VVKLNSGVDY RGVLACLDGY MNIALEQTEE YVNGQLKNKY
61 GDAFIRGNNV LYISTQKRRMLocalizationUniProt · AlphaFold · HPA
Whether an antibody against LSM6 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.39
- Highest tissue expression
- 17 nTPM
Expression across tissuesHPA
Tissue
- lymph node: 17 nTPM
- tonsil: 13 nTPM
- thymus: 12 nTPM
- spleen: 11 nTPM
- adipose tissue: 11 nTPM
- bone marrow: 11 nTPM
Single-cell type
- oocytes: 309 nCPM
- differentiating spermatogonia: 225 nCPM
- extravillous trophoblasts: 220 nCPM
- gastric progenitor cells: 217 nCPM
- migrating cytotrophoblasts: 178 nCPM
- early primary spermatocytes: 165 nCPM
Immune cell
- non-classical monocyte: 60 nTPM
- intermediate monocyte: 44 nTPM
- naive B-cell: 34 nTPM
- memory B-cell: 33 nTPM
- total PBMC: 31 nTPM
- T-reg: 28 nTPM
Brain region
- cerebellum: 15 nTPM
- midbrain: 11 nTPM
- hypothalamus: 10 nTPM
- medulla oblongata: 10 nTPM
- pons: 10 nTPM
- spinal cord: 9.9 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.45
- gnomAD pLI
- 0.87
- gnomAD missense Z
- 1.54
- DepMap mean gene effect
- -0.9
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- maturation of SSU-rRNA
- mRNA catabolic process
- mRNA splicing, via spliceosome
- RNA splicing
- tRNA processing
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of LSM6 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads LSM6 as an antibody target. Whether an autoantibody or antibody against LSM6 could matter depends on whether native LSM6 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
LSM6 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label LSM6 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...